1 / 6

RNA Based Therapeutics

Application (Cardiovascular, Kidney Diseases, Oncology, Infectious diseases, Metabolic disorders) and End Users (Research, Therapeutics, Diagnosis) - Global Opportunity Analysis and Industry Forecast, 2013 - 2020<br>Read more at:http://bit.ly/2CzOFSp

shawn966
Download Presentation

RNA Based Therapeutics

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. RNA Based Therapeutics Market Global Opportunity Analysis and Industry Forecast, 2013 - 2020

  2. RNA Based Therapeutics Market is expected to garner $1.2 billion by 2020, registering a CAGR of 28.4% during the forecast period 2014 - 2020. The Global RNA based therapeutics Market has garnered significant attention in the recent years due to its potential to treat variety of chronic diseases such as cancer, diabetes, AIDS, Tuberculosis and certain cardiovascular conditions. • RNA based therapeutics market is segmented into technology, application, end-users and geography. Technology segment is further categorized as enabling technologies and enabled technologies. The segment of enabling technologies comprises of Microarrays, Labeling, Purification, Linear amplification, qRT-PCR and Inhibition

  3. Despite being in the clinical research phase, the RNA based therapeutics is been explored as a promising treatment option for the diseases which are difficult to treat.Development of this therapeutics is based on promising technologies such as RNA interference technology (RNAi), antisense technology and SMaRT technology. RNAi technology and antisense technology together are gaining prominence in the research industry, as these technologies provide base sequence to develop RNA drugs. • RNAi technology works by causing destruction of specific mRNA molecules; whereas, antisense technology works by synthesizing strand of RNA from known gene sequence. These newly synthesized RNA strands then itself binds to mRNA and make mRNA inactive. Gene silencing potential of RNA based therapeutics is the primary driver for the growth of this market. The other drivers include target specificity and selectivity of RNAi therapeutics, more intense product focus versus platform technologies and virtual drug development models that enable companies to reduce the research cost.

  4. KEY BENEFITS • An in-depth analysis of research and clinical developments within RNA based therapeutics market is provided and light is shed on market dynamics that would prove crucial in understanding the market • Quantitative analysis of the current market and estimations through 2013-2020 would assist strategists to design business strategies to capitalize on the prevailing opportunities in the market • Competitive structure of RNA based therapeutics market is analyzed through Porters Five Forces model and provides in-depth understanding of the influencing factors for commercialization of RNA therapeutics • Detailed study of the strategies of key leaders, partnerships, acquisitions and clinical trials in the RNA based therapeutics market would be informative for professionals in the corporate sector • Pin-point analysis of geographic segments would assist in identification of most profitable segments to capitalize on

  5. KEY MARKET SEGMENTS • MARKET BY TECHNOLOGY • Microarrays • Labeling • MARKET BY APPLICATION • Cardiovascular • Kidney Diseases • MARKET BY END USERS • Research • Therapeutics • MARKET BY GEOGRAPHY • North America • Europe • Asia Pacific

  6. RNA Based Therapeutics Market by Technology (Inhibition, Microarrays, Labeling, Purification, qRT-PCR, RNA Interference (RNAi) technologies, RNA antisense), Application (Cardiovascular, Kidney Diseases, Oncology, Infectious diseases, Metabolic disorders) and End Users (Research, Therapeutics, Diagnosis) - Global Opportunity Analysis and Industry Forecast, 2013 - 2020

More Related